Literature DB >> 28817974

Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies.

Niccolò Candelise1, Matthias Schmitz1, Susana Margarida Da Silva Correia1, Amandeep Singh Arora1, Anna Villar-Piqué1, Saima Zafar1, Franc Llorens2, Maria Cramm1, Inga Zerr1.   

Abstract

INTRODUCTION: The development of in vitro protein misfolding amplification assays for the detection and analysis of abnormally folded proteins, such as proteinase K resistant prion protein (PrPres) was a major innovation in the prion field. In prion diseases, these types of assays imitate the pathological conversion of the cellular PrP (PrPC) into a proteinase resistant associated conformer or amyloid, called PrPres. Areas covered: The most prominent protein misfolding amplification assays are the protein misfolding cyclic amplification (PMCA), which is based on sonication and the real-time quaking-induced conversion (RT-QuIC) technique based on shaking. The more recently established RT-QuIC is fully automatic and enables the monitoring of misfolded protein aggregates in real-time by using a fluorescent dye. Expert commentary: RT-QuIC is a very robust and highly reproducible test system which is applicable in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies.

Entities:  

Keywords:  Real-time quaking-induced conversion; aggregation; prion protein; protein misfolding; sporadic Creutzfeldt-Jakob disease

Mesh:

Substances:

Year:  2017        PMID: 28817974     DOI: 10.1080/14737159.2017.1368389

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  7 in total

1.  Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency.

Authors:  Matthias Schmitz; Niccolo Candelise; Eirini Kanata; Franc Llorens; Katrin Thüne; Anna Villar-Piqué; Susana Margarida da Silva Correia; Dimitra Dafou; Theodoros Sklaviadis; Dietmar Appelhans; Inga Zerr
Journal:  Mol Neurobiol       Date:  2019-12-17       Impact factor: 5.590

Review 2.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

3.  Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis.

Authors:  Inga Zerr; Maria Cramm; Susana Margarida da Silva Correia; Saima Zafar; Anna Villar-Piqué; Franc Llorens; Matthias Schmitz
Journal:  Front Bioeng Biotechnol       Date:  2020-11-19

4.  Pentosan polysulfate induces low-level persistent prion infection keeping measurable seeding activity without PrP-res detection in Fukuoka-1 infected cell cultures.

Authors:  Hanae Takatsuki; Morikazu Imamura; Tsuyoshi Mori; Ryuichiro Atarashi
Journal:  Sci Rep       Date:  2022-05-13       Impact factor: 4.379

Review 5.  Disease modification in Parkinsonism: obstacles and ways forward.

Authors:  M Höllerhage; M Klietz; G U Höglinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-13       Impact factor: 3.850

Review 6.  Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases.

Authors:  Hasier Eraña; Jorge M Charco; Ezequiel González-Miranda; Sandra García-Martínez; Rafael López-Moreno; Miguel A Pérez-Castro; Carlos M Díaz-Domínguez; Adrián García-Salvador; Joaquín Castilla
Journal:  Biomolecules       Date:  2020-03-19

Review 7.  Biomarkers: Our Path Towards a Cure for Alzheimer Disease.

Authors:  Rawan Tarawneh
Journal:  Biomark Insights       Date:  2020-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.